Never Run Out Of Buyers To Sell To.

2Strands is a pre-seed stage precision diagnostics startup developing an ultrasensitive yet cost effective ctDNA-based MRD blood test to monitor cancer recurrence and treatment response, powered by our differentiated rare mutant allele-enrichment technology. Our mission is to empower clinicians and patients worldwide with accessible, high-performance cancer monitoring beyond elite health systems.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.